Clinic
Planned Parenthood Mar Monte, INC
Planned Parenthood Mar Monte, INC was paid $9.01M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is J7307, Etonogestrel (contraceptive) implant system, including implant and supplies — 13% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD MAR MONTE, INC
SALINAS, CA 93901
SALINAS, CA 93901
33aNPI1053364034assigned 05/18/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$9.01M
24GClaims132,224
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#39 of 288
Median peer was paid$2.15M
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,581 | $1.57M | |
| 2019 | 18,380 | $1.14M | |
| 2020 | 17,620 | $1.13M | |
| 2021 | 20,170 | $1.59M | |
| 2022 | 13,366 | $1.02M | |
| 2023 | 19,318 | $1.31M | |
| 2024incomplete | 17,789 | $1.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 13% | 1,349 | 1,347 | $1.16M |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 11% | 1,297 | 1,291 | $961K |
| J7304 | Contraceptive supply, hormone containing patch, each | 9.6% | 993 | 991 | $867K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.1% | 7,621 | 7,314 | $821K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.5% | 4,702 | 4,592 | $763K |
| J3490 | Unclassified drugs | 7.5% | 17,499 | 14,479 | $678K |
| S4993 | Contraceptive pills for birth control | 7.2% | 5,382 | 5,364 | $652K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.6% | 5,479 | 5,395 | $410K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4.2% | 10,219 | 9,813 | $383K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.9% | 2,596 | 2,587 | $350K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.5% | 1,398 | 1,398 | $312K |
| 11981 | 2.8% | 1,375 | 1,369 | $255K |
34 more codes
| 87806 | 2.7% | 9,550 | $245K | |
| 11976 | 2.2% | 2,800 | $198K | |
| 99201 | 1.8% | 2,009 | $159K | |
| A4267 | Contraceptive supply, condom, male, each | 1.6% | 10,598 | $144K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.5% | 547 | $139K |
| S0190 | Mifepristone, oral, 200 mg | <1% | 1,191 | $72K |
| 58300 | <1% | 598 | $56K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,727 | $52K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 525 | $42K |
| 99401 | <1% | 1,868 | $36K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 2,386 | $30K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 105 | $28K |
| 99000 | <1% | 7,432 | $27K | |
| 81025 | <1% | 8,518 | $27K | |
| 99402 | <1% | 557 | $18K | |
| 58301 | <1% | 424 | $17K | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 5,244 | $16K |
| 83986 | <1% | 5,329 | $16K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 4,142 | $16K |
| S5000 | Prescription drug, generic | <1% | 2,018 | $15K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 100 | $13K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 15 | $10K |
| Q3014 | Telehealth originating site facility fee | <1% | 368 | $9K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,006 | $5K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 1,384 | $4K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 162 | $3K |
| 11982 | <1% | 26 | $2K | |
| 81002 | <1% | 901 | $2K | |
| 85018 | <1% | 334 | $771.57 | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 368 | $769.80 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 33 | $165.42 |
| 86901 | <1% | 25 | $50.75 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 12 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOSTIFF, TOM (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Planned Parenthood Mar Monte, INC | Gilroy, CA | $3.92M |
| Planned Parenthood Mar Monte, INC | Seaside, CA | $3.62M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.